financetom
Business
financetom
/
Business
/
HeartBeam's Heart Monitoring Device Receives US FDA Clearance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HeartBeam's Heart Monitoring Device Receives US FDA Clearance
Dec 16, 2024 6:34 AM

09:07 AM EST, 12/16/2024 (MT Newswires) -- HeartBeam ( BEAT ) said Monday its HeartBeam ( BEAT ) device has received 510(k) clearance from the US Food and Drug Administration for comprehensive arrhythmia assessment.

The device tracks heart signals from three directions to provide heart health information, the company said.

Shares of HeartBeam ( BEAT ) were up more than 11% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved